Search all trials

Find therapies in clinical trials near you – page 35

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Ammonium Chloride

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational

Romania

Participants:0–17 years · 18–64 years · 65+ years
Substances:Upadacitinib

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drug

Study on Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis and Portal Hypertension

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Oesophageal carcinoma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Marginal zone lymphoma+1

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study of Tislelizumab, LBL-007, and BGB-15025 in Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Bgb-15025 Citrate

Contact Research Centre

Microsatellite instability cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Neurodermatitis

Not recruiting

Investigational

Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Rocatinlimab

Contact Research Centre

Find therapies in clinical trials near you – page 35

427 trials match your criteria

Small cell lung cancer recurrent

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Dermatitis atopic

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Non-small cell lung cancer

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Hepatic cirrhosis

Study on Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis and Portal Hypertension

Oesophageal carcinoma

Study on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer

Neoplasm

Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

Marginal zone lymphoma+1

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Non-small cell lung cancer+1

Study of Tislelizumab, LBL-007, and BGB-15025 in Patients with Advanced Non-Small Cell Lung Cancer

Microsatellite instability cancer+1

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Non-small cell lung cancer

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Neurodermatitis

Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.